“meds that cause weight gain”的搜索结果，显示 1-10 项，共有 10843 项

1. 诊断与治疗 - 妙佑医疗国际

   For some people, weight-loss medicines or weight ... Healthcare professionals may recommend specific self-care steps based on overall health and the cause of ...

2. 症状与病因 - 妙佑医疗国际

   As more fluid builds up and the ascites progresses to moderate or severe, your belly can look swollen or feel heavy or tight. You also might notice weight gain ...

3. Bardet-Biedl syndrome (BBS)

   Setmelanotide (Imcivree) is approved by the U.S. Food and Drug Administration for weight management in people with BBS who are overweight and age 2 and older.

4. 体重减轻Diet pills, supplements and surgery - 妙佑医疗国际

   Dietary supplements for weight loss. Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/. Accessed March 10, 2023.

5. 体重减轻Diet pills, supplements and surgery - 妙佑医疗国际

   Dietary supplements for weight loss. Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/. Accessed March 10, 2023.

6. 症状与病因 - 妙佑医疗国际

   The risk is linked to hormone therapy medicines that combine estrogen and progesterone. Obesity. Obesity increases the risk of breast cancer. Radiation exposure ...

7. 体重减轻Diet pills, supplements and surgery - 妙佑医疗国际

   Dietary supplements for weight loss. Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/. Accessed March 10, 2023.

8. 双相障碍药物与体重增长

   McIntyre RS, et al. Psychotropic drug-related weight gain and its treatment. American Journal of Psychiatry. 2024; doi:10.1176/appi.ajp.20230922. Post RM ...

9. Chemotherapy for colon cancer

   Being tired is a common side effect due to the impact on red blood cells. Hair loss. Not all chemotherapy medicines cause this, but hair thinning or total hair ...

10. 体重减轻Diet pills, supplements and surgery - 妙佑医疗国际

    Dietary supplements for weight loss. Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/. Accessed March 10, 2023.